SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Biotherapy Inc. (ADVB)
ADVB 0.350+1.6%2:12 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Stephen Goldfarb who started this subject7/12/2004 11:48:24 AM
From: Stephen Goldfarb   of 19
 
Advanced Biotherapy is an under-recognized company that is pioneering treatment for autoimmune diseases. The company has demonstrated positive results in treating multiple sclerosis, rheumatoid arthritis, and skin diseases such as psoriasis. The company has recently announced FDA Phase I testing of HIV patients who have become resistant to conventional treatment. The company has broad patent protection. The company is registered with the SEC and files regular reports. The most recent news release indicated submission of a patent application to the U.S. Patent and Trademark Office for the treatment of acne vulgaris (pimples). Early testing shows positive results.
The company is making progress toward licensing their procedures and further FDA testing. Information about the company is readily available on the SEC website, the company website, and in company news. There have been a series of recent positive news announcements. In my view, the prospect for share price appreciation is considerable once the company becomes recognized.

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext